Phenotypic and Genotypic Characterization of Pan-Drug-Resistant Klebsiella pneumoniae Isolated in Qatar
Open Access
- 19 March 2024
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 13 (3) , 275
Abstract
In secondary healthcare, carbapenem-resistant Enterobacterales (CREs), such as those observed in Klebsiella pneumoniae, are a global public health priority with significant clinical outcomes. In this study, we described the clinical, phenotypic, and genotypic characteristics of three pan-drug-resistant (PDR) isolates that demonstrated extended resistance to conventional and novel antimicrobials. All patients had risk factors for the acquisition of multidrug-resistant organisms, while microbiological susceptibility testing showed resistance to all conventional antimicrobials. Advanced susceptibility testing demonstrated resistance to broad agents, such as ceftazidime-avibactam, ceftolozane–tazobactam, and meropenem–vaborbactam. Nevertheless, all isolates were susceptible to cefiderocol, suggested as one of the novel antimicrobials that demonstrated potent in vitro activity against resistant Gram-negative bacteria, including CREs, pointing toward its potential therapeutic role for PDR pathogens. Expanded genomic studies revealed multiple antimicrobial-resistant genes (ARGs), including blaNMD-5 and blaOXA derivative types, as well as a mutated outer membrane porin protein (OmpK37).Keywords
All Related Versions
Funding Information
- Hamad Medical Corporation (MRC-04-22-522)
This publication has 55 references indexed in Scilit:
- Combination eravacycline therapy for ventilator‐associated pneumonia due to carbapenem‐resistant Acinetobacter baumannii in patients with COVID‐19: A case seriesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2024
- Antimicrobial surveillance: A 20-year history of the SMART approach to addressing global antimicrobial resistance into the futureInternational Journal of Antimicrobial Agents, 2023
- Molecular detection of carbapenem resistance genes in rectal swabs from patients in Gulf Cooperation Council hospitalsJournal of Hospital Infection, 2021
- Molecular characterization of clinical carbapenem-resistant Enterobacterales from QatarEuropean Journal of Clinical Microbiology & Infectious Diseases, 2021
- Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative InfectionsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2020
- Colistin resistance emerges in pandrug-resistant Klebsiella pneumoniae epidemic clones in Rio de Janeiro, BrazilInternational Journal of Antimicrobial Agents, 2019
- Management of carbapenem-resistant Enterobacteriaceae infectionsClinical Microbiology and Infection, 2019
- Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approachIntensive Care Medicine, 2017
- Review of Eravacycline, a Novel Fluorocycline Antibacterial AgentDrugs, 2016
- Emergence of clinical Klebsiella pneumoniae producing OXA-232 carbapenemase in SingaporeNew Microbes and New Infections, 2013